Načítá se...
Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer
The widespread use of trastuzumab in the past decade has led to a significant and measureable improvement in the survival of patients with human epidermal growth factor receptor-2 (HER2) overexpressing breast cancer, and in many ways has redefined the natural history of this aggressive breast cancer...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3528960/ https://ncbi.nlm.nih.gov/pubmed/23143215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-012-2328-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|